ArticleEuropean journal of cancer (Oxford, England : 1990)2010

Experimental treatment of oestrogen receptor (ER) positive breast cancer with tamoxifen and brivanib alaninate, a VEGFR-2/FGFR-1 kinase inhibitor: a potential clinical application of angiogenesis inhibitors.

Roshani R Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.